Syncona leads Freeline's £88M series B

By Jennie Walters | Jun 22, 2018 | 7:03 PM GMT

Freeline Therapeutics Ltd. (London, U.K.) raised £88.4 million ($116.9 million) on June 19 in a series B round

Read the full 185 word article

How to gain access

Continue reading with a
two-week free trial.